NODAL
protein-codingnodal growth differentiation factor, the group of Transforming growth factor beta superfamily
Gene summary
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate the mature protein, which regulates early embryonic development. This protein is required for maintenance of human embryonic stem cell pluripotency and may play a role in human placental development. Mutations in this gene are associated with heterotaxy, a condition characterized by random orientation of visceral organs with respect to the left-right axis. [provided by RefSeq, Aug 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~16.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0700112
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:1060197
Submitter: ClinGen
*NODAL* was first reported in relation to autosomal dominant congenital heart disease with heterotaxy syndrome in 1997 (Gebbia et al., PMID: 9354794). This gene has been associated with isolated congenital heart disease and heterotaxy, visceral, 5, autosomal. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanisms, inheritance pattern and phenotypic variability. Therefore, the two entities have been lumped into one disease entity. At least 12 unique variants (missense, nonsense, frameshift, splice site) have been reported in 14 probands in seven publications (PMID: 19064609, 19553149, 19933292, 30293987, 34328347, 34666056, 38605286). The mechanism of pathogenicity appears to be loss-of-function. Some variants were inherited from healthy parents showing approximately 50% penetrance (PMID: 38605286). This gene-disease relationship is supported by biochemical function data showing that NODAL is a crucial signaling molecule belonging to the transforming growth factor-β (TGF-β) superfamily, and animal models recapitulating the disease phenotype (PMID: 17287255, 12231623, 30446628). In summary, there is definitive evidence to support the relationship between the *NODAL* gene and autosomal dominant congenital heart disease with heterotaxy syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date August 5th, 2025 (SOP Version 11).
Inheritance Pattern: AD
Disease ID:MONDO:0700112
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0700112
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0700112
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Gastrointestinal; Pulmonary; Renal
Intervention: Cardiovascular
Rationale: The condition can involve congenital cardiac anomalies, and awareness may allow early management; Cardiac transplantation has been described
Comments: The condition can involve multiple congenital anomalies; Cardiac transplantation has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NODAL variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018055.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 30 | 3 | 39 | ||
| missense | 2 | 83 | 12 | 2 | 99 | |
| nonsense | 3 | 2 | 2 | 7 | ||
| start loss | 1 | 1 | ||||
| frameshift | 2 | 6 | 4 | 12 | ||
| splice donor/acceptor (+/-2bp) | 3 | 1 | 4 | |||
| Total | 5 | 14 | 96 | 42 | 5 | 162 |
Highest pathogenic variant AF is 0.000012997248
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060525.3 | 3 | MANE Select | |
| Ensembl | ENSP00000287139.3 | 3 | MANE Select | |
| RefSeq | NP_001316835.1 | 2 | Standard | |
| Ensembl | ENSP00000394468.1 | 3 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| ndr1 | Danio rerio | Structure: hatching gland cell Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- TGF-beta signaling pathway - Homo sapiens (human)
- Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human)
- TGF-Core
- Cardiac Progenitor Differentiation
- Differentiation Pathway
Biological Process
- negative regulation of transcription by RNA polymerase II
- trophectodermal cellular morphogenesis
- neural fold formation
- liver development
- placenta development
Molecular Function
- cytokine activity
- transforming growth factor beta receptor binding
- growth factor activity
- morphogen activity
- type I activin receptor binding
Cellular Component
- extracellular space
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000287139
- Coding exons
- 3
- Length
- 15637
- Individuals with no LoFs
- 125742
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 6
- Defined
- 125748
- p
- 0.0000239
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.971 | 156 | 194 | 0.804 | 0.0000114 | 2239 |
| Missense (PolyPhen) | 57 | 78.963 | 0.72186 | 958 | ||
| Synonymous | 1.31 | 68 | 83.2 | 0.817 | 0.00000474 | 707 |
| Loss of Function | 3.39 | 1 | 15.3 | 0.0654 | 8.26e-7 | 146 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000026 | 0.000026 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Essential for mesoderm formation and axial patterning during embryonic development. {ECO:0000250}.;
- Disease
- DISEASE: Heterotaxy, visceral, 5, autosomal (HTX5) [MIM:270100]: A form of visceral heterotaxy, a complex disorder due to disruption of the normal left-right asymmetry of the thoracoabdominal organs. Visceral heterotaxy or situs ambiguus results in randomization of the placement of visceral organs, including the heart, lungs, liver, spleen, and stomach. The organs are oriented randomly with respect to the left-right axis and with respect to one another. It can been associated with variety of congenital defects including cardiac malformations. HTX5 clinical features include situs inversus viscerum or situs ambiguus, congenital heart defect, transposition of the great vessels ventricular septal defect, atrial septal defect, truncus communis, and dextrocardia. {ECO:0000269|PubMed:19064609, ECO:0000269|PubMed:9354794}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.426
Intolerance Scores
- LoFtool
- 0.272
- RVIS EVS
- -0.29
- RVIS percentile EVS
- 32.94
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.834
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |